Adaptive Hedged Multi-Asset Income ETF (AMAX)
Live price chart, market sentiment, and community perspectives for Adaptive Hedged Multi-Asset Income ETF (AMEX: AMAX).
Live price chart, market sentiment, and community perspectives for Adaptive Hedged Multi-Asset Income ETF (AMEX: AMAX).
On our desk, we are closely tracking AMAX's extreme duration risk. With a duration of 15.31 years, this fund exhibits severe sensitivity to interest rate shifts. Even though the trailing yield hits 11.72% via options premiums on digital assets and Treasuries, the underlying asset allocation leaves fixed income and credit investors vulnerable to macroeconomic rate volatility.
Looking at the institutional flows for Q2 2026, 22 hedge funds and large institutions maintain $45.9M invested in AMAX, showing a slight increase in capital deployed despite mixed short interest metrics. Short interest saw heavy swings earlier in the year, spiking by 300.4% in April and 249.8% in May, before dropping 33.8% in July to 75,699 shares. Market sentiment remains cautiously split on whether institutional accumulation will offset the micro-cap liquidity drag.
From a quantitative execution standpoint, trading AMAX requires extreme caution regarding transaction costs. The fund's fee structure includes a high 1.36% expense ratio coupled with a severe 1.34% average bid-ask spread. When evaluating entry points around its 52-week low range of $7.35 to $7.41, these frictional costs heavily erode short-term alpha on every execution.
As a risk manager reviewing AMAX's portfolio characteristics, I flag its micro-cap size of roughly $49.78M to $69M alongside poor downside protection. While the RSI oscillator climbed out of oversold territory in late June—signaling a potential shift from a downward to an upward trend—the overall risk profile remains remarkably weak for retail participants relying on options-driven income funds.
Examining the market sentiment across technical channels, AMAX's recent price action hovering around $7.41 reflects a tight 52-week window bounded by a low of $7.35 and a high of $8.50. With average trading volumes hovering around 34,000 to 63,000 shares, the low liquidity relative to its days-to-cover ratio of 1.2 to 2.2 days means position sizing must be strictly managed to avoid execution slippage.
Explore plasma cleansing, somatic organ swaps, and BCI.